Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD19 antibodies with reduced immunogenicity

Anti-CD19 antibodies with reduced immunogenicity

US Patent 8691952 · Granted Apr 8, 2014

Estimated economic value: $55,924,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Orthogonal mutations for heterodimerization2025
Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use2025
Compositions and methods for analyte detection2024
Engineered heme-binding compositions and uses thereof2024
Aqueous biomolecule coupling on CO2-plasma-activated surfaces2024
Fibronectin based scaffold domain proteins that bind PCSK92024
Microbe-binding molecules and uses thereof2023
Engineered microbe-targeting molecules and uses thereof2023
CRP capture/detection of gram positive bacteria2023
Pathogen vaccines and methods of producing and using the same2023
Compositions and methods for analyte detection2023
Compositions and methods for analyte detection2023